跳至主要内容
临床试验/NCT00978835
NCT00978835已完成不适用

Tailored Case Management for Diabetes and Hypertension

Duke University2 个研究点 分布在 1 个国家目标入组 377 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
377
试验地点
2
主要终点
Blood Pressure

研究概览

简要总结

Diabetes and hypertension co-exist in approximately 10 million people in the USA and constitute severe risk factors for the development of such complications as heart and kidney disease. The investigators propose a randomized controlled trial in patients of community primary care practices to study a tailored telephone-administered behavioral intervention to improve control of blood pressure and blood sugar in patients with both hypertension and diabetes. The investigators hypothesize that 20% more patients talking to a nurse every other month about ways to improve blood pressure and blood sugar control will bring their blood pressure under control when compared to patients who talk with the nurse only about general health issues. If successful in improving control of these diseases this intervention can easily be adopted in other community primary care practices to lessen the burden of diabetes and hypertension in the USA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Enrolled and receiving primary care at one of 9 participating clinics in North Carolina
  • Diagnosis of diabetes as determined by billing data
  • Taking medication for diabetes
  • Diagnosis of hypertension as determined by billing data
  • Taking medication for hypertension
  • Most recent (within one year) Hemoglobin A1c >= 7.5%

排除标准

  • Active psychosis
  • Hospitalization for stroke, myocardial infarction (MI), or coronary artery revascularization in the past 6 months
  • Type I diabetes
  • Does not speak English
  • No access to a telephone
  • Institution-dwelling or receiving comprehensive professional home health care
  • Hearing or speech inadequate for long interactive phone conversations
  • Terminal illness or active treatment for cancer
  • Cognitive impairment too severe to understand instructions

结局指标

主要结局

Blood Pressure

时间窗: 2 years

次要结局

  • Hemoglobin A1c(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验